Cargando…
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Adoptive cell therapy using chimeric antigen receptor (CAR)-engineered T cells has emerged as a very promising approach to combating cancer. Despite its ability to eliminate tumors shown in some clinical trials, CAR-T cell therapy involves some significant safety challenges, such as cytokine release...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210295/ https://www.ncbi.nlm.nih.gov/pubmed/28049484 http://dx.doi.org/10.1186/s13045-016-0379-6 |